May 4, 2018
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of BRAF-positive anaplastic thyroid cancer
- FDA Drug Shortages
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- National Drug Code Directory (updated)
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
.png)
No hay comentarios:
Publicar un comentario